Back to Search
Start Over
Figure S1 from Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Patient disposition
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....202ce1043c77888a619f4b916e9483a5
- Full Text :
- https://doi.org/10.1158/1078-0432.22478334.v1